During the last session, Arbutus Biopharma Corp (NASDAQ:ABUS)’s traded shares were 0.41 million, with the beta value of the company hitting 2.05. At the end
In the last trading session, 1.09 million shares of the Arbutus Biopharma Corp (NASDAQ:ABUS) were traded, and its beta was 2.05. Most recently the company’s
Arbutus Biopharma Corp (NASDAQ:ABUS)’s traded shares stood at 1.02 million during the last session, with the company’s beta value hitting 2.03. At the close of
In last trading session, Arbutus Biopharma Corp (NASDAQ:ABUS) saw 0.66 million shares changing hands with its beta currently measuring 2.06. Company’s recent per share price
Arbutus Biopharma Corp (NASDAQ:ABUS) has a beta value of 2.05 and has seen 6.08 million shares traded in the last trading session. The company, currently
During the last session, Arbutus Biopharma Corp (NASDAQ:ABUS)’s traded shares were 12.42 million, with the beta value of the company hitting 2.09. At the end
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
